Academic Content and Language Evaluation of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (5910)
All Articles published online
|
Publishing Process of This Article
|
Jun 28, 2015 (publication date) through Apr 25, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Yang GY, Guo S, Dong CY, Wang XQ, Hu BY, Liu YF, Chen YW, Niu J, Dong JH. Integrin αvβ6 sustains and promotes tumor invasive growth in colon cancer progression. World J Gastroenterol 2015; 21(24): 7457-7467 [PMID: 26139991 DOI: 10.3748/wjg.v21.i24.7457] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v21/i24/7457.htm |
| Number | Citing Articles |
| 1 |
Alexandra Desnoyers, Carlos González, Pedro Pérez-Segura, Atanasio Pandiella, Eitan Amir, Alberto Ocaña. Integrin ανβ6 Protein Expression and Prognosis in Solid Tumors: A Meta-Analysis. Molecular Diagnosis & Therapy 2020; 24(2): 143 doi: 10.1007/s40291-020-00450-1
|
| 2 |
Beatrice S. Ludwig, Horst Kessler, Susanne Kossatz, Ute Reuning. RGD-Binding Integrins Revisited: How Recently Discovered Functions and Novel Synthetic Ligands (Re-)Shape an Ever-Evolving Field. Cancers 2021; 13(7): 1711 doi: 10.3390/cancers13071711
|
| 3 |
Yunyu Lian, Silue Zeng, Sai Wen, Xingyang Zhao, Chihua Fang, Ning Zeng. Review and Application of Integrin Alpha v Beta 6 in the Diagnosis and Treatment of Cholangiocarcinoma and Pancreatic Ductal Adenocarcinoma. Technology in Cancer Research & Treatment 2023; 22 doi: 10.1177/15330338231189399
|
| 4 |
Tanushree Ganguly, Nadine Bauer, Ryan A. Davis, Cameron C. Foster, Rebecca E. Harris, Sven H. Hausner, Emilie Roncali, Sarah Y. Tang, Julie L. Sutcliffe. Preclinical Evaluation of68Ga- and177Lu-Labeled Integrin αvβ6-Targeting Radiotheranostic Peptides. Journal of Nuclear Medicine 2023; 64(4): 639 doi: 10.2967/jnumed.122.264749
|
| 5 |
Pengwei Yan, Huanfeng Zhu, Li Yin, Lijun Wang, Peng Xie, Jinjun Ye, Xuesong Jiang, Xia He. Integrin αvβ6 Promotes Lung Cancer Proliferation and Metastasis through Upregulation of IL-8–Mediated MAPK/ERK Signaling. Translational Oncology 2018; 11(3): 619 doi: 10.1016/j.tranon.2018.02.013
|
| 6 |
Leila Mohammadi, Bashir Mosayyebi , Mahsa Imani, Mohammad Rahmati . Dexamethasone Reduces Cell Adhesion and Migration of T47D Breast Cancer
Cell Line. Anti-Cancer Agents in Medicinal Chemistry 2022; 22(13): 2494 doi: 10.2174/1871520621666201214150427
|
| 7 |
Samy A.F. Morad, Lance C. Bridges, Alex D. Almeida Larrea, Anthony L. Mayen, Matthew R. MacDougall, Traci S. Davis, Mark Kester, Myles C. Cabot. Short-chain ceramides depress integrin cell surface expression and function in colorectal cancer cells. Cancer Letters 2016; 376(2): 199 doi: 10.1016/j.canlet.2016.03.049
|
| 8 |
Shunsuke Nakamura, Aya Matsuno, Masashi Ueda. Improvement of biodistribution profile of a radiogallium-labeled, αvβ6 integrin-targeting peptide probe by incorporation of negatively charged amino acids. Annals of Nuclear Medicine 2020; 34(8): 575 doi: 10.1007/s12149-020-01483-6
|
| 9 |
Zequn Li, Pengfei Lin, Chao Gao, Cheng Peng, Song Liu, Huijie Gao, Ben Wang, Jiayong Wang, Jun Niu, Weibo Niu. Integrin β6 acts as an unfavorable prognostic indicator and promotes cellular malignant behaviors via ERK-ETS1 pathway in pancreatic ductal adenocarcinoma (PDAC). Tumor Biology 2016; 37(4): 5117 doi: 10.1007/s13277-015-4353-7
|
| 10 |
Ping-Hsiu Wu, Abayomi Emmanuel Opadele, Yasuhito Onodera, Jin-Min Nam. Targeting Integrins in Cancer Nanomedicine: Applications in Cancer Diagnosis and Therapy. Cancers 2019; 11(11): 1783 doi: 10.3390/cancers11111783
|
| 11 |
Tatiana S. Gerashchenko, Nikita M. Novikov, Nadezhda V. Krakhmal, Sofia Y. Zolotaryova, Marina V. Zavyalova, Nadezhda V. Cherdyntseva, Evgeny V. Denisov, Vladimir M. Perelmuter. Markers of Cancer Cell Invasion: Are They Good Enough?. Journal of Clinical Medicine 2019; 8(8): 1092 doi: 10.3390/jcm8081092
|
| 12 |
Eiki Ichihara, David Westover, Catherine B. Meador, Yingjun Yan, Joshua A. Bauer, Pengcheng Lu, Fei Ye, Amanda Kulick, Elisa de Stanchina, Robert McEwen, Marc Ladanyi, Darren Cross, William Pao, Christine M. Lovly. SFK/FAK Signaling Attenuates Osimertinib Efficacy in Both Drug-Sensitive and Drug-Resistant Models of EGFR-Mutant Lung Cancer. Cancer Research 2017; 77(11): 2990 doi: 10.1158/0008-5472.CAN-16-2300
|
| 13 |
Fanni Li, Yukui Shang, Feiyu Shi, Lei Zhang, Jun Yan, Qi Sun, Junjun She. <p>Expression of Integrin β6 and HAX-1 Correlates with Aggressive Features and Poor Prognosis in Esophageal Squamous Cell Carcinoma</p>. Cancer Management and Research 2020; : 9599 doi: 10.2147/CMAR.S274892
|
| 14 |
Ian I. Cardle, Michael C. Jensen, Suzie H. Pun, Drew L. Sellers. Optimized serum stability and specificity of an αvβ6 integrin-binding peptide for tumor targeting. Journal of Biological Chemistry 2021; 296: 100657 doi: 10.1016/j.jbc.2021.100657
|
| 15 |
Jian-Rui Chen, Jing-Tong Zhao, Zhen-Zhen Xie. Integrin-mediated cancer progression as a specific target in clinical therapy. Biomedicine & Pharmacotherapy 2022; 155: 113745 doi: 10.1016/j.biopha.2022.113745
|
| 16 |
Markus Nieberler, Ute Reuning, Florian Reichart, Johannes Notni, Hans-Jürgen Wester, Markus Schwaiger, Michael Weinmüller, Andreas Räder, Katja Steiger, Horst Kessler. Exploring the Role of RGD-Recognizing Integrins in Cancer. Cancers 2017; 9(12): 116 doi: 10.3390/cancers9090116
|
| 17 |
Lixing Ma, Kang Song, Jinfeng Zang. Integrin β5 is an independent prognostic marker for intrahepatic cholangiocarcinoma in a Chinese population. Experimental and Therapeutic Medicine 2023; 26(5) doi: 10.3892/etm.2023.12231
|
| 18 |
Naomi O. Hodgins, Wafa' T. Al-Jamal, Julie T.-W. Wang, Rebecca Klippstein, Pedro M. Costa, Jane K. Sosabowski, John F. Marshall, John Maher, Khuloud T. Al-Jamal. Investigating in vitro and in vivo αvβ6 integrin receptor-targeting liposomal alendronate for combinatory γδ T cell immunotherapy. Journal of Controlled Release 2017; 256: 141 doi: 10.1016/j.jconrel.2017.04.025
|
| 19 |
Long Zhao, Linxuan Huang, Shuyi Yu, Junheng Zheng, Hua Wang, Yan Zhang. Decellularized tongue tissue as an in vitro model for studying tongue cancer and tongue regeneration. Acta Biomaterialia 2017; 58: 122 doi: 10.1016/j.actbio.2017.05.062
|
| 20 |
Yurie Soejima, Miho Takeuchi, Nao Miyamoto, Motoji Sawabe, Toshio Fukusato. ITGB6-Knockout Suppresses Cholangiocarcinoma Cell Migration and Invasion with Declining PODXL2 Expression. International Journal of Molecular Sciences 2021; 22(12): 6303 doi: 10.3390/ijms22126303
|
| 21 |
Hao Liu, Liquan Gao, Xinhe Yu, Lijun Zhong, Jiyun Shi, Bing Jia, Nan Li, Zhaofei Liu, Fan Wang. Small-animal SPECT/CT imaging of cancer xenografts and pulmonary fibrosis using a 99mTc-labeled integrin αvβ6-targeting cyclic peptide with improved in vivo stability. Biophysics Reports 2018; 4(5): 254 doi: 10.1007/s41048-018-0071-1
|